0

Purchase Short-Term Access

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose
Stephanos J. Hadziyannis, MD; Hoel Sette, MD; Timothy R. Morgan, MD; Vijayan Balan, MD; Moises Diago, MD; Patrick Marcellin, MD; Giuliano Ramadori, MD; Henry Bodenheimer, MD; David Bernstein, MD; Mario Rizzetto, MD; Stefan Zeuzem, MD; Paul J. Pockros, MD; Amy Lin, MS; Andrew M. Ackrill, PhD; PEGASYS International Study Group*
Annals of Internal Medicine 2004;140:346-355. doi:10.7326/0003-4819-140-5-200403020-00010

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)